Cabozantinib/ipilimumab/nivolumab interaction
Tài liệu tham khảo
Azari AE, et al. First case of hemophagocytic lymphohistiocytosis secondary to cabozantinib with checkpoint inhibitors. Rheumatology 60: E167-E168, No. 5, May 2021. Available from: URL: http://rheumatology.oxfordjournals.org/